Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
Condition(s):Chronic Myeloid Leukemia; Acute Lymphoblastic LeukemiaLast Updated:February 17, 2016Withdrawn
Hide Studies Not Open or Pending
Condition(s):Chronic Myeloid Leukemia; Acute Lymphoblastic LeukemiaLast Updated:February 17, 2016Withdrawn
Condition(s):Chronic Myelogenous LeukemiaLast Updated:September 1, 2020Completed
Condition(s):Chronic Myeloid Leukemia; Philadelphia Chromosome; Chronic Myeloid Leukemia in Chronic PhaseLast Updated:June 27, 2022Completed
Condition(s):Chronic Myelogenous Leukemia; Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaLast Updated:March 18, 2024Completed
Condition(s):Leukemia; Leukemia, Myeloid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Hematologic DiseasesLast Updated:August 29, 2018Completed
Condition(s):Chronic Myelogenous LeukemiaLast Updated:October 14, 2013Completed
Condition(s):Chronic Myelogenous Leukemia – Chronic PhaseLast Updated:August 18, 2021Terminated
Condition(s):Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaLast Updated:March 21, 2024Active, not recruiting
Condition(s):Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic PhaseLast Updated:February 23, 2021Completed
Condition(s):Chronic Myelogenous Leukemia; Leukemia, Lymphoblastic, Acute, Philadelphia-PositiveLast Updated:January 30, 2015Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.